PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
ARKG vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

ARKG vs. IHE

Last updated Jun 24, 2026

ARKG (ARK Genomic Revolution Multi-Sector ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds. ARKG is actively managed, while IHE is passively managed. Over the past 10 years, ARKG returned 8.67%/yr vs 8.99%/yr for IHE. A 0.56 correlation means they provide meaningful diversification when combined. ARKG charges 0.75%/yr vs 0.42%/yr for IHE.

Performance

ARKG vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARKG achieves a 24.30% return, which is significantly higher than IHE's 11.65% return. Both investments have delivered pretty close results over the past 10 years, with ARKG having a 8.67% annualized return and IHE not far ahead at 8.99%.

ARKG

1D
-1.07%
1M
17.41%
YTD
24.30%
6M
19.48%
1Y
52.71%
3Y*
3.17%
5Y*
-16.56%
10Y*
8.67%

IHE

1D
1.60%
1M
3.16%
YTD
11.65%
6M
10.97%
1Y
46.87%
3Y*
18.43%
5Y*
10.55%
10Y*
8.99%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. IHE - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF		24.30%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%46.61%
IHE
iShares U.S. Pharmaceuticals ETF		11.65%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%

Correlation

The correlation between ARKG and IHE is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.49

Correlation (3Y)
Calculated over the trailing 3-year period

0.46

Correlation (5Y)
Calculated over the trailing 5-year period

0.48

Correlation (10Y)
Calculated over the trailing 10-year period

0.54

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2014

0.56

The correlation between ARKG and IHE shifts across timeframes, from 0.46 (3 years) to 0.56 (all time), reflecting how their relationship changes across market environments.

ARKG vs. IHE - Sectors Allocation Comparison

Sectors
ARKG
IHE

Healthcare

99.3%
100.0%

Financial Services

0.5%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

ARKG
99.3%
IHE
100.0%

Financial Services

ARKG
0.5%
IHE

-

Basic Materials

ARKG

-

IHE

-

Communication Services

ARKG

-

IHE

-

Consumer Cyclical

ARKG

-

IHE

-

Consumer Defensive

ARKG

-

IHE

-

Energy

ARKG

-

IHE

-

Industrials

ARKG

-

IHE

-

Real Estate

ARKG

-

IHE

-

Technology

ARKG

-

IHE

-

Utilities

ARKG

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

ARK Genomic Revolution Multi-Sector ETF

iShares U.S. Pharmaceuticals ETF

Often compared with ARKG:
ARKG vs. ARKKARKG vs. XBIARKG vs. IBBARKG vs. GNOMARKG vs. IDNAARKG vs. ARKQARKG vs. ARKW
Often compared with IHE:
IHE vs. PPHIHE vs. XPHIHE vs. XLVIHE vs. VYMIHE vs. PJPIHE vs. IAKIHE vs. BBP

Return for Risk

ARKG vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
ARKG
ARKG Risk / Return Rank: 3636
Overall Rank
ARKG Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3838
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3434
Omega Ratio Rank
ARKG Calmar Ratio Rank: 4040
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3232
Martin Ratio Rank
IHE
IHE Risk / Return Rank: 8787
Overall Rank
IHE Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 9090
Sortino Ratio Rank
IHE Omega Ratio Rank: 8282
Omega Ratio Rank
IHE Calmar Ratio Rank: 9191
Calmar Ratio Rank
IHE Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

ARKGIHEDifference
Sharpe ratioReturn per unit of total volatility
1.25
2.74

-1.49

Sortino ratioReturn per unit of downside risk
1.91
3.95

-2.03

Omega ratioGain probability vs. loss probability

1.22

1.46

-0.24

Calmar ratioReturn relative to maximum drawdown

1.93

5.56

-3.63

Martin ratioReturn relative to average drawdown

4.58

17.09

-12.51

ARKG vs. IHE - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.25, which is lower than the IHE Sharpe Ratio of 2.74. The chart below compares the historical Sharpe Ratios of ARKG and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

ARKG vs. IHE - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for ARKG and IHE.

Loading charts...

Drawdown Indicators

ARKGIHEDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-38.20%

-45.39%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-8.47%

-19.04%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

-15.92%

-36.04%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

-16.03%

-64.15%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

-29.59%

-54.00%

Current Drawdown

Current decline from peak

-67.78%

-0.70%

-67.08%

Average Drawdown

Average peak-to-trough decline

-36.02%

-7.90%

-28.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.53%

2.75%

+8.78%

Volatility

ARKG vs. IHE - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.19% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 5.27%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

ARKGIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.19%

5.27%

+9.92%

Volatility (6M)

Calculated over the trailing 6-month period

30.91%

12.68%

+18.23%

Volatility (1Y)

Calculated over the trailing 1-year period

42.54%

17.22%

+25.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.93%

16.28%

+29.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.29%

18.05%

+23.24%

ARKG vs. IHE - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than IHE's 0.42% expense ratio.

Dividends

ARKG vs. IHE - Dividend Comparison

ARKG has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.56%.

PositionTTM20252024202320222021202020192018201720162015
ARKG
ARK Genomic Revolution Multi-Sector ETF		0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%0.00%0.00%
IHE
iShares U.S. Pharmaceuticals ETF		1.56%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions

ARKG and IHE have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (15.19%) compared to IHE (5.27%). In terms of maximum drawdown, ARKG dropped -83.59% vs IHE's -38.20%.

On 10-year performance, IHE leads with 8.99% vs 8.67% for ARKG. On fees, IHE is cheaper at 0.42% per year. On volatility, IHE has been the lower-risk option at 5.27%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, IHE has performed better with a 8.99% return vs 8.67%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IHE is cheaper with a 0.42% expense ratio, compared with 0.75% for ARKG.

IHE has the higher dividend yield at 1.56%, compared with 0.00% for ARKG.

They also come from different issuers: ARK and iShares. Their fees differ too: 0.75% for ARKG and 0.42% for IHE.

IHE currently has the higher Sharpe Ratio (2.74 vs 1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARKG and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer